ID

18446

Description

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00359112

Link

https://clinicaltrials.gov/show/NCT00359112

Keywords

  1. 11/5/16 11/5/16 -
Uploaded on

November 5, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
body mass index > or = to 25 kg/m2.
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
hba1c > or =7% and < or =10% at screening.
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
fpg > or = 7.0mmol/l (126mg/dl) at visit 2.
Description

Plasma fasting glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0583513
receiving at least 0.85g of metformin at constant dose(s) for at least 8 weeks prior to visit 1a.
Description

Metformin Dose Constant

Data type

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1948059
female subjects must be postmenopausal or using effective contraceptive measures.
Description

Gender Contraceptive methods | Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0232970
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of any other oral antidiabetic drug other than metformin within 12 weeks prior to screening.
Description

Antidiabetics Oral | Metformin

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0025598
subjects with clinically significant ongoing oedema requiring pharmacological treatment or with a history of oedema requiring pharmacological treatment.
Description

Edema Clinical Significance Requirement Pharmacotherapy | Edema Requirement Pharmacotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0013604
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0013216
UMLS CUI [2,1]
C0013604
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0013216
subjects with a history of severe hypoglycaemia.
Description

Hypoglycemia Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
renal disease or renal dysfunction.
Description

Kidney Disease | Renal dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C3279454
presence of clinically significant hepatic disease.
Description

Liver disease Clinical Significance

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C2826293
presence of unstable or severe angina or known nyha grade i-iv congestive heart failure.
Description

Angina, Unstable | Angina Pectoris Severe | Congestive heart failure | New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0002962
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0018802
UMLS CUI [4]
C1275491
subjects who have had a previous myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft or cerebrovascular accident within 3 months prior to screening.
Description

Myocardial Infarction | Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Bypass Surgery | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C2936173
UMLS CUI [3]
C0010055
UMLS CUI [4]
C0038454

Similar models

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Body mass index
Item
body mass index > or = to 25 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c > or =7% and < or =10% at screening.
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg > or = 7.0mmol/l (126mg/dl) at visit 2.
boolean
C0583513 (UMLS CUI [1])
Metformin Dose Constant
Item
receiving at least 0.85g of metformin at constant dose(s) for at least 8 weeks prior to visit 1a.
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1948059 (UMLS CUI [1,3])
Gender Contraceptive methods | Postmenopausal state
Item
female subjects must be postmenopausal or using effective contraceptive measures.
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Antidiabetics Oral | Metformin
Item
use of any other oral antidiabetic drug other than metformin within 12 weeks prior to screening.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0025598 (UMLS CUI [2])
Edema Clinical Significance Requirement Pharmacotherapy | Edema Requirement Pharmacotherapy
Item
subjects with clinically significant ongoing oedema requiring pharmacological treatment or with a history of oedema requiring pharmacological treatment.
boolean
C0013604 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0013216 (UMLS CUI [1,4])
C0013604 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0013216 (UMLS CUI [2,3])
Hypoglycemia Severe
Item
subjects with a history of severe hypoglycaemia.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Kidney Disease | Renal dysfunction
Item
renal disease or renal dysfunction.
boolean
C0022658 (UMLS CUI [1])
C3279454 (UMLS CUI [2])
Liver disease Clinical Significance
Item
presence of clinically significant hepatic disease.
boolean
C0023895 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Angina, Unstable | Angina Pectoris Severe | Congestive heart failure | New York Heart Association Classification
Item
presence of unstable or severe angina or known nyha grade i-iv congestive heart failure.
boolean
C0002965 (UMLS CUI [1])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3])
C1275491 (UMLS CUI [4])
Myocardial Infarction | Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Bypass Surgery | Cerebrovascular accident
Item
subjects who have had a previous myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft or cerebrovascular accident within 3 months prior to screening.
boolean
C0027051 (UMLS CUI [1])
C2936173 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C0038454 (UMLS CUI [4])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial